The trial targeted a patient population with high BMI and extensive skin involvement, averaging over 39 kg/m²
This is the first controlled pharmacologic study to demonstrate that treatment of obesity improved PsA disease measures
Patients can now get the starting 2.5 mg dose for $299 per month
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
Walmart, with nearly 4,600 pharmacies nationwide, will serve as the first in-store pickup pharmacy for LillyDirect's self-pay single-dose vials
_256_384.jpg)
Tirzepatide is a prescription based the first and only dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
The SURPASS-CVOT study met its primary objective by demonstrating that Mounjaro (tirzepatide) was non-inferior to Trulicity
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Express Scripts to add Zepbound to National Preferred Formulary
Subscribe To Our Newsletter & Stay Updated
